Accès ouvert

Effect of dolutegravir-based versus efavirenz-based antiretroviral therapy on excessive weight gain in adult treatment-naïve HIV patients at Matsanjeni health center, Eswatini: a retrospective cohort study

Article scientifique 2024 Anglais

Résumé

Abstract Background There is limited data on dolutegravir (DTG)-associated weight gain from settings with a dual burden of HIV and overnutrition. Methods In Eswatini (at Matsanjeni), among 156 and 160 adult patients on DTG-based and EFV-based antiretroviral therapy (ART), respectively, we studied excessive weight gain (BMI at 24 months ART greater than baseline and ≥25 kg/m 2 ). Results The median BMI increase in DTG-based patients was 1.09 (IQR:-0.28,3.28) kg/m 2 compared to 0.20 (IQR:-0.85,2.18) kg/m 2 in EFV-based patients ( p value = 0.001). DTG-based ART predicted excessive weight gain (aOR 2.61;95% CI:1.39–4.93). Conclusion Practitioners should consider DTG-based regimens as one of the risk factors for overweight/obesity.

Citer ce document

Mukuna, D., Decroo, T., Nyapokoto, C. (2024). Effect of dolutegravir-based versus efavirenz-based antiretroviral therapy on excessive weight gain in adult treatment-naïve HIV patients at Matsanjeni health center, Eswatini: a retrospective cohort study. https://doi.org/10.1186/s12981-023-00591-3

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Voir l'article sur le site de la revue

Auteur(s)

Didier M. Mukuna Tom Decroo Clara M. Nyapokoto

Statistiques

Consultations : 2

Téléchargements : 0